Europe Companion Animal Diagnostics Market

The Europe companion animal diagnostics market is projected to reach USD 0.70 billion by 2031 from USD 0.46 billion in 2026 at a CAGR of 8.6% during the forecast period”.

he increasing trend of pet ownership in European countries has increased the demand for companion animal diagnostics. Pets have been integrated into families as family members, creating emotional bonding that makes owners willing to spend on their health care. This change in perspective has led to a shift in spending on veterinary care, preventive treatments, and advanced diagnostics. There is an echo in the interest in pet health with human healthcare trends: the constant check-ups and vaccinations, the wellness plans, all part of keeping their companions living healthier, longer lives. With pets being considered part of the family, the need for high-tech diagnostics, including blood tests, imaging scans, and genetic screening, has grown sharply. This is also matched by the growth of veterinary clinics and hospitals that provide high-quality services. This growing bond fosters further developments and progress in the animal companion health care industry. In this report, the Europe companion animal diagnostics market has been segmented on the basis of product, technology, animal type, application, end user, and country.

Prominent players in this market include IDEXX (US), Zoetis Services LLC (US), Mars, Incorporated (US), FUJIFILM Corporation (Japan), bioMérieux (France), Thermo Fisher Scientific (US), Virbac (France), Neogen Corporation (US), INDICAL BIOSCIENCE GmbH (Germany), IDvet (France), Randox Laboratories Ltd. (UK), Shenzhen Mindray Animal Medical Technology Co., LTD. (China), Bionote USA Inc. (US), Boule (Sweden), EUROIMMUN Medizinische Labordiagnostika AG (Germany), Biopanda Reagents Ltd (UK), Nova Biomedical (US), Megacor Veterinary Diagnostics (Austria), Eurolyser Diagnostica GmbH (Austria), URIT MEDICAL ELECTRONIC CO., LTD. (China), Fassisi GmbH (Germany), Swissavans AG (Switzerland), Ring Biotechnology Co Ltd (China), and Alvedia (France).

To know about the assumptions considered for the study download the pdf brochure

IDEXX (US)

IDEXX is one of the major companies in the Europe companion animal diagnostics market, which develops, manufactures, and markets products & services primarily for the companion animal, veterinary, livestock, poultry, dairy, and water testing markets. The company focuses more on the identification & consummation of acquisitions that will either enhance existing businesses or develop new businesses. IDEXX mainly concentrates on strengthening its product line through product development and R&D investment. The company increased investments for R&D activities in the CAG segment to USD 236.2 million in 2022 from USD 140.6 million in 2021, which rose at a rate of 67.2%. By retaining premium pricing on selective segments, the company is able to continue its delivery of higher-quality products to customers.

ZOETIS SERVICES LLC (US)

Zoetis is one of the leading companies in the veterinary care market. As part of its growth strategy, the company focuses on the discovery & development of new chemical, biopharmaceutical, and biological entities, besides product lifecycle innovation through its R&D group. The company has R&D operations focusing on diagnostics, devices, data, digital, and other technological innovations. In 2023, Zoetis spent USD 614 million, in 2022, it spent USD 539 million, and in 2021, it spent USD 508 million on R&D. To sustain its market share in the Europe companion animal diagnostics market, the company utilized different organic & inorganic growth strategies. Zoetis introduced Vetscan OptiCell (Analyzer) in May 2024. The Vetscan OptiCell is a cartridge-based AI-powered hematology analyzer, which offers advanced Complete Blood Count (CBC) analysis. In 2021, Zoetis entered Canada, Spain, Germany, Italy, the Netherlands, Belgium, and Luxembourg.

Mars, Incorporated (US)

Mars, Incorporated has a long list of products offered under the Petcare segment. For several years, the company has always expanded its services through acquisitions. Given its vast scope of services, ranging from veterinary care to diagnostic tests, the company can comfortably cope with the growing need for animal healthcare services. Mars has a strong presence worldwide. It has developed an efficient distribution network across regions and markets and taps into it to reach a broad, diversified customer base. It is highly represented in North America with more than veterinary health services, including veterinary and diagnostic businesses in 15 countries.

Related Reports:

Europe Companion Animal Diagnostics Market by Product (Consumables, Instruments), Technology (Clinical Biochemistry, Molecular Diagnostics), Application (Clinical Pathology, Virology, Hematology), Animal (Dogs, Cats), End User - Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com